Glucotrack, Inc. Files 8-K

Ticker: GCTK · Form: 8-K · Filed: Dec 29, 2025 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateDec 29, 2025
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, regulatory

TL;DR

Glucotrack (GCTK) filed an 8-K on 12/29/25. Check for updates.

AI Summary

Glucotrack, Inc. filed an 8-K on December 29, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ.

Why It Matters

This filing indicates Glucotrack, Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — This is a routine filing with no immediate indication of significant financial distress or major corporate events.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing does not detail the specific content of the Regulation FD disclosure, only that it is being reported.

What financial statements or exhibits are included with this 8-K?

The filing indicates that Financial Statements and Exhibits are being provided, but their specific content is not detailed in this header information.

When was Glucotrack, Inc. previously known as Integrity Applications, Inc.?

The company changed its name from Integrity Applications, Inc. on December 3, 2010.

What is Glucotrack, Inc.'s principal executive office address?

The principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

What is the SIC code for Glucotrack, Inc.?

The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Filing Stats: 485 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-12-29 08:11:05

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 29, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing